Estimated Drug Overdose Deaths Averted by North America's First Medically-Supervised Safer Injection Facility
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Illicit drug overdose remains a leading cause of premature mortality in urban settings worldwide. We sought to estimate the number of deaths potentially averted by the implementation of a medically supervised safer injection facility (SIF) in Vancouver, Canada. METHODOLOGY/PRINCIPAL FINDINGS: The number of potentially averted deaths was calculated using an estimate of the local ratio of non-fatal to fatal overdoses. Inputs were derived from counts of overdose deaths by the British Columbia Vital Statistics Agency and non-fatal overdose rates from published estimates. Potentially-fatal overdoses were defined as events within the SIF that required the provision of naloxone, a 911 call or an ambulance. Point estimates and 95% Confidence Intervals (95% CI) were calculated using a Monte Carlo simulation. Between March 1, 2004 and July 1, 2008 there were 1004 overdose events in the SIF of which 453 events matched our definition of potentially fatal. In 2004, 2005 and 2006 there were 32, 37 and 38 drug-induced deaths in the SIF's neighbourhood. Owing to the wide range of non-fatal overdose rates reported in the literature (between 5% and 30% per year) we performed sensitivity analyses using non-fatal overdose rates of 50, 200 and 300 per 1,000 person years. Using these model inputs, the number of averted deaths were, respectively: 50.9 (95% CI: 23.6-78.1); 12.6 (95% CI: 9.6-15.7); 8.4 (95% CI: 6.5-10.4) during the study period, equal to 1.9 to 11.7 averted deaths per annum. CONCLUSIONS/SIGNIFICANCE: Based on a conservative estimate of the local ratio of non-fatal to fatal overdoses, the potentially fatal overdoses in the SIF during the study period could have resulted in between 8 and 51 deaths had they occurred outside the facility, or from 6% to 37% of the total overdose mortality burden in the neighborhood during the study period. These data should inform the ongoing debates over the future of the pilot project.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“While several studies have pointed to the positive impact of the SIF on public disorder [15], HIV risk behaviour [16], management of overdose [17,18] and use of addiction treatment [19], its role with regard to hospitalization for CIRI remains unknown.”
From Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study (2010) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Release from prison–a high risk of death for former inmates
Binswanger, I. A., Stern, M. F., Deyo, R. A., Heagerty, P. J., Cheadle, A., Elmore, J. G., & Koepsell, T. D. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa064115 · Cited by 1,684 · cited 1×
“Other factors affecting overdose risk include age [23], drug choice [24], exposure to addiction treatment [25] and incarceration history [26].”
BackgroundTom, S. A., & Marye Kate Aldridge Charitable Educational Trust (1999) · Cited by 360
Heroin Overdose: Research and Evidence-Based Intervention
Darke, S. (2003) · Journal of Urban Health: Bulletin of the New York Academy of Medicine · doi:10.1093/jurban/jtg022 · Cited by 332 · cited 1×
“The local incidence of nonfatal overdose (nfODDTES) was estimated from a review of crosssectional and longitudinal surveys of active IDU in both domestic and international settings [3,5,14,23,24,31,45–52].”
MethodPredictors of non-fatal overdose among a cohort of polysubstance-using injection drug users
Kerr, T., Fairbairn, N., Tyndall, M., Marsh, D., Li, K., Montaner, J., & Wood, E. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.07.009 · Cited by 313 · cited 9×
“IDU in DTES N (4700, 500) Non-fatal OD rate Scenario 1: N (0.05, 0.01) Scenario 2: N (0.2, 0.01) Scenario 3: N (0.3, 0.01) = March 1, 2004 to December 31, 2004/WJanuary 1, 2008 to July 1, 2008 doi:10.1371/journal.pone.0003351.t002”
BackgroundMethodInfluentialSelf-citationOverdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non‐fatal overdose
DARKE, S., ROSS, J., & HALL, W. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.9134059.x · Cited by 302
Safer injection facility use and syringe sharing in injection drug users
Kerr, T., Tyndall, M., Li, K., Montaner, J., & Wood, E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66475-6 · Cited by 294 · cited 1×
“; and a reduction in the prevalence of risk factors for HIV infection, such as syringe sharing”
Self-citationDeath and survival in a cohort of heroin addicts from London clinics: a 22‐year follow‐up study
OPPENHEIMER, E., TOBUTT, C., TAYLOR, C., & ANDREW, T. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03309.x · Cited by 272 · cited 1×
“For injection drug users (IDU), the annual rate of fatal overdose is estimated to between one and three per cent per year and is the primary contributor to mortality rates many times higher than in non-IDU populations [4– 7].”
BackgroundWood, E. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040774 · Cited by 267 · cited 1×
“; a decrease in local measures of drug-related disorder, including public injecting”
BackgroundSelf-citationThe quantification of mortality resulting from the regular use of illicit opiates
Hulse, G. K., English, D. R., Milne, E., & Holman, C. D. J. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.9422216.x · Cited by 258
Morbidity associated with non‐fatal heroin overdose
Warner‐Smith, M., Darke, S., & Day, C. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00132.x · Cited by 208
Mcgregor, C., Darke, S., Ali, R., & Christie, P. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9357016.x · Cited by 204
Summary of findings from the evaluation of a pilot medically supervised safer injecting facility
Wood, E., Tyndall, M. W., Montaner, J. S., & Kerr, T. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.060863 · Cited by 187 · cited 3×
“The pilot facility has been the subject of a comprehensive evaluation [9,10].”
BackgroundResultSelf-citationGossop, M., Griffiths, P., Powis, B., Williamson, S., & Strang, J. (1996) · BMJ · doi:10.1136/bmj.313.7054.402 · Cited by 185
Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose
DARKE, S., ROSS, J., & HALL, W. (1996) · Addiction · doi:10.1111/j.1360-0443.1996.tb02289.x · Cited by 180
Drug-related mortality and its impact on adult mortality in eight European countries
Bargagli, A. M., Hickman, M., Davoli, M., Perucci, C. A., Schifano, P., Buster, M., Brugal, T., & Vicente, J. (2006) · European Journal of Public Health · doi:10.1093/eurpub/cki168 · Cited by 170 · cited 1×
“. For injection drug users (IDU), the annual rate of fatal overdose is estimated to between one and three per cent per year and is the primary contributor to mortality rates many times higher than in non-IDU populations”
BackgroundAttendance at Supervised Injecting Facilities and Use of Detoxification Services
Wood, E., Tyndall, M. W., Zhang, R., Stoltz, J.-A., Lai, C., Montaner, J. S. G., & Kerr, T. (2006) · New England Journal of Medicine · doi:10.1056/nejmc052939 · Cited by 168 · cited 1×
“Among its findings are a significant increase in uptake to drug and alcohol treatment [11]; a decrease in local measures of drug-related disorder, including public injecting [12]; and a reduction in the prevalence of risk factors for HIV infection, such as syringe sharing [13].”
BackgroundSelf-citationIdentifying Injection Drug Users at Risk of Nonfatal Overdose
Coffin, P. O., Tracy, M., Bucciarelli, A., Ompad, D. C., Vlahov, D., & Galea, S. (2007) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2007.tb01846.x · Cited by 159 · cited 1×
“Other factors affecting overdose risk include age [23], drug choice [24], exposure to addiction treatment [25] and incarceration history [26].”
BackgroundA cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility
Andresen, M. A., & Boyd, N. (2010) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2009.03.004 · Cited by 154 · cited 1×
“Our results differ from those in an unpublished cost-effectiveness report prepared for Canada's federal health minister”
ResultKerr, T. H., Small, W., Moore, D., & Wood, E. (2007) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2006.12.008 · Cited by 146 · cited 1×
“Although this issue requires further study, IDU who experience supervision of a nurse within the SIF may subsequently be more cautious when injecting in environments which are not supervised by trained emergency personnel [33].”
BackgroundSelf-citationThe ratio of non‐fatal to fatal heroin overdose
Darke, S., Mattick, R. P., & Degenhardt, L. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00474.x · Cited by 118 · cited 1×
“and included a wide confidence interval in the Monte Carlo simulation. For the latter, we completed a sensitivity analysis to account for the wide range of non-fatal overdose rates reported in the literature. Model outputs such as the DTES fatal overdose rate and non-fatal to fatal overdose ratio are not substantially…”
ResultWood, E., Kerr, T., Lloyd-Smith, E., Buchner, C., Marsh, D. C., Montaner, J. S., & Tyndall, M. W. (2004) · Harm Reduction Journal · doi:10.1186/1477-7517-1-9 · Cited by 107 · cited 3×
“This approach has been deemed unethical [9].”
BackgroundSelf-citationHeroin overdose among young injection drug users in San Francisco
Ochoa, K. C., Davidson, P. J., Evans, J. L., Hahn, J. A., Page, K. A., & Moss, A. R. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.04.012 · Cited by 103 · cited 1×
“The local incidence of nonfatal overdose (nfODDTES) was estimated from a review of crosssectional and longitudinal surveys of active IDU in both domestic and international settings [3,5,14,23,24,31,45–52].”
MethodDeterminants of overdose incidents among illicit opioid users in 5 Canadian cities
Fischer, B. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1031416 · Cited by 102 · cited 2×
“Illicit drug overdose remains a leading cause of death and disability in many urban settings worldwide [1–3].”
BackgroundMethodDrug-related overdoses within a medically supervised safer injection facility
Kerr, T. H., TYNDALL, M. W., Lai, C., Montaner, J. S. G., & Wood, E. (2006) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2006.05.008 · Cited by 100
Self-citationUnintentional Poisoning Deaths—United States, 1999-2004
(2007) · JAMA · doi:10.1001/jama.297.12.1309 · Cited by 89
Wood, E., Tyndall, M. W., Qui, Z., Zhang, R., Montaner, J. S. G., & Kerr, T. (2006) · American Journal of Public Health · doi:10.2105/ajph.2004.057828 · Cited by 84 · cited 1×
“We believe the authors’ population-level estimates of overdose risk differed due to the above issues as well as failure to account for the higher risk drug-using patterns of the SIF clientele [10,21].”
BackgroundSelf-citationDarke, S. G., Williamson, A., Ross, J. E., Mills, K. L., Havard, A., & Teesson, M. (2007) · Journal of Urban Health · doi:10.1007/s11524-006-9156-0 · Cited by 82 · cited 1×
“Other factors affecting overdose risk include age [23], drug choice [24], exposure to addiction treatment [25] and incarceration history [26].”
BackgroundUNINTENTIONAL POISONING DEATHS—UNITED STATES, 1999_2004
(2007) · CRC Press eBooks · doi:10.3109/9781420044805-28 · Cited by 82
DARKE, S., WILLIAMSON, A., ROSS, J., & TEESSON, M. (2005) · Drug and Alcohol Review · doi:10.1080/09595230500286005 · Cited by 74 · cited 1×
“The local incidence of nonfatal overdose (nfODDTES) was estimated from a review of crosssectional and longitudinal surveys of active IDU in both domestic and international settings [3,5,14,23,24,31,45–52].”
MethodMilloy, M.-J. S., Kerr, T., Mathias, R., Zhang, R., Montaner, J. S., Tyndall, M., & Wood, E. (2008) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990802122457 · Cited by 69 · cited 3×
“, in drug choice, mode of administration or dose—within the apparent safety of an SIF [14].”
BackgroundMethodInfluentialSelf-citationThe Sydney Medically Supervised Injecting Centre: reducing harm associated with heroin overdose
van Beek, I., Kimber, J., Dakin, A., & Gilmour, S. (2004) · Critical Public Health · doi:10.1080/09581590400027528 · Cited by 66 · cited 1×
“Despite the international evidence suggesting a beneficial effect of SIF on overdose mortality [16–18], we are unaware of any peer-reviewed studies that quantify the number of deaths prevented by such a facility.”
BackgroundChanges in Canadian heroin supply coinciding with the Australian heroin shortage
Wood, E., Stoltz, J., Li, K., Montaner, J. S. G., & Kerr, T. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01385.x · Cited by 65 · cited 1×
“We have recently shown large fluctuations in local drug purity[22].”
BackgroundSelf-citationAccidental overdose among injecting drug users in Dorset, UK
Bennett, G. A., & Higgins, D. S. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.94811798.x · Cited by 63
Wood, R. A., Wood, E., Lai, C., TYNDALL, M. W., Montaner, J. S. G., & Kerr, T. H. (2008) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2008.01.003 · Cited by 62
Self-citationAntiretroviral medication use among injection drug users: two potential futures
Wood, E., Schechter, M. T., Tyndall, M. W., Montaner, J. S. G., O'Shaughnessy, M. V., & Hogg, R. S. (2000) · AIDS · doi:10.1097/00002030-200006160-00021 · Cited by 54 · cited 2×
“In this analysis, we sought to estimate the number of overdose deaths averted by a supervised injection facility using methods described previously [16,31,34,35].”
MethodSelf-citationHeroin overdose among a treatment sample of injecting drug misusers: accident or suicidal behaviour?
Vingoe, L., Welch, S., Farrell, M., Strang, J., Vingoe, L., Welch, S., Farrell, M., & Strang, J. (1999) · Journal of Substance Use · doi:10.3109/14659899909053019 · Cited by 48 · cited 1×
“The local incidence of nonfatal overdose (nfODDTES) was estimated from a review of crosssectional and longitudinal surveys of active IDU in both domestic and international settings [3,5,14,23,24,31,45–52].”
MethodUnderlying causes of cocaine, amphetamine and opioid related deaths in Australia
Degenhardt, L. J., Roxburgh, A., & Barker, B. (2005) · Journal of Clinical Forensic Medicine · doi:10.1016/j.jcfm.2004.11.003 · Cited by 31 · cited 1×
“Illicit drug overdose remains a leading cause of death and disability in many urban settings worldwide [1–3].”
BackgroundDrug-related Overdose Deaths in British Columbia and Ontario, 1992–2004
Fischer, B., Popova, S., Rehm, J. T., & Ivsins, A. (2006) · Canadian Journal of Public Health · doi:10.1007/bf03405347 · Cited by 16
The Costs of Triple-Drug Anti-HIV Therapy for Adults in the Americas
Montaner, J. S. G. (1998) · JAMA · doi:10.1001/jama.279.16.1259 · Cited by 13 · cited 5×
“Citation: Milloy MJS, Kerr T, Tyndall M, Montaner J, Wood E (2008) Estimated Drug Overdose Deaths Averted by North America’s First Medically-Supervised Safer Injection Facility.”
MethodInfluentialSelf-citationDeciding Life and Death in the Courtroom: Debate and Clarification
Paris, J. J., & Gargaro, W. J. (1998) · JAMA · doi:10.1001/jama.279.16.1259-b · Cited by 8
The Costs of Triple-Drug Anti-HIV Therapy for Adults in the Americas
Montaner, J. S. G. (1998) · JAMA · doi:10.1001/jama.279.16.1263-a · Cited by 6
Self-citation
Research works printed but not linked: 2
- Selby P Kahan M Srivastava A 2007 Safe Injecting Sites (SIS): Need for equipose and evidence of net benefit to illicit drug users. Canadian Medical Association journal eLetters
- Remis R Leclerc P Routledge R Taylor C Bruneau J 1998 Consortium to characterize injection drug users in Canada (Montreal, Toronto and Vancouver) Toronto, Ontario Department of Public Health Sciences, University of Toronto
Cited by
Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0137-5 · Cited by 639
Self-citationSupervised injection services: What has been demonstrated? A systematic literature review
Potier, C., Laprévote, V., Dubois-Arber, F., Cottencin, O., & Rolland, B. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.10.012 · Cited by 495
McNeil, R., Small, W., Wood, E., & Kerr, T. (2014) · Social Science & Medicine · doi:10.1016/j.socscimed.2014.01.010 · Cited by 284
Self-citationKennedy, M. C., Karamouzian, M., & Kerr, T. (2017) · Current HIV/AIDS Reports · doi:10.1007/s11904-017-0363-y · Cited by 256
Self-citationMarrazzo, J. M., del Río, C., Holtgräve, D. R., Cohen, M. S., Kalichman, S. C., Mayer, K. H., Montaner, J. S. G., Wheeler, D. P., Grant, R. M., Grinsztejn, B. G. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.7999 · Cited by 143
Self-citation
Metadata
- Authors
- Milloy, M.-J. S., Kerr, T., Tyndall, M., Montaner, J., & Wood, E.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- Wood, Evan
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-10-07
- Volume
- 3
- Issue
- 10
- Pages
- e3351
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2556397
- OpenAlex
- W2017933780
- Cited by
- 117
- References
- 40
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 8 · 2022: 9 · 2021: 8 · 2020: 8 · 2019: 9 · 2018: 7 · 2017: 14 · 2016: 7 · 2015: 4 · 2014: 6 · 2013: 4 · 2012: 7
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Abbott Laboratories
- Gilead Sciences
- Health Canada
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- drug overdose deaths, naloxone, harm reduction, Vancouver, Monte Carlo simulation
- MeSH terms
- British Columbia, Community Health Centers, Humans, Monte Carlo Method, Substance Abuse, Intravenous, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.